ASX - By Stock
|
SPL |
Re:
Are you a pumper dumper?
|
|
Biostock
|
7 |
2.5K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
7
|
2.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Are you a pumper dumper?
|
|
Biostock
|
7 |
2.5K |
0 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
7
|
2.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Are you a pumper dumper?
|
|
Biostock
|
7 |
2.5K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
7
|
2.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Shareholders newsletter 03/06/22
|
|
Biostock
|
22 |
6.2K |
6 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
22
|
6.2K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Three years of silence
|
|
Biostock
|
11 |
3.4K |
0 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
11
|
3.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Shareholders newsletter 03/06/22
|
|
Biostock
|
22 |
6.2K |
1 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
22
|
6.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Shareholders newsletter 03/06/22
|
|
Biostock
|
22 |
6.2K |
4 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
22
|
6.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
DEP Move in Play
|
|
Biostock
|
21 |
5.7K |
0 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
21
|
5.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Three years of silence
|
|
Biostock
|
11 |
3.4K |
3 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
11
|
3.4K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Webinar this Friday 8th April with Jackie Fairley
|
|
Biostock
|
68 |
20K |
1 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
68
|
20K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
CEO replacement
|
|
Biostock
|
18 |
6.8K |
0 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
18
|
6.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
DEP Move in Play
|
|
Biostock
|
21 |
5.7K |
4 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
21
|
5.7K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
ASCO 22 and Starpharma
|
|
Biostock
|
19 |
5.5K |
0 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
19
|
5.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 in VIRALEZE virucidal against influenza A and B
|
|
Biostock
|
40 |
10K |
6 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
40
|
10K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
ASCO 22 and Starpharma
|
|
Biostock
|
19 |
5.5K |
2 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
19
|
5.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus
|
|
Biostock
|
78 |
22K |
0 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
78
|
22K
|
0
|
|
ASX - By Stock
|
SPL |
leadership qualities ??
|
|
Biostock
|
0 |
271 |
2 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
0
|
271
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus
|
|
Biostock
|
78 |
22K |
1 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
78
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus
|
|
Biostock
|
78 |
22K |
3 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
78
|
22K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
PATIENCE
|
|
Biostock
|
54 |
17K |
4 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
54
|
17K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus
|
|
Biostock
|
78 |
22K |
3 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
78
|
22K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
PATIENCE
|
|
Biostock
|
54 |
17K |
4 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
54
|
17K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
PATIENCE
|
|
Biostock
|
54 |
17K |
3 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
54
|
17K
|
3
|
|
ASX - By Stock
|
SPL |
Lloyds and viraleze - waiting still.
|
|
Biostock
|
0 |
373 |
3 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
0
|
373
|
3
|
|
ASX - By Stock
|
SPL |
Re:
PATIENCE
|
|
Biostock
|
54 |
17K |
3 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
54
|
17K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
ASCO - but where is SPL clinical data?
|
|
Biostock
|
2 |
885 |
2 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
2
|
885
|
2
|
|
ASX - By Stock
|
SPL |
ASCO - but where is SPL clinical data?
|
|
Biostock
|
2 |
885 |
5 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
2
|
885
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
Biostock
|
158 |
77K |
1 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
158
|
77K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
VP research has departed SPL
|
|
Biostock
|
35 |
11K |
2 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Application for quotation of securities - SPL
|
|
Biostock
|
6 |
1.8K |
2 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
6
|
1.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
Biostock
|
158 |
77K |
3 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
158
|
77K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
Biostock
|
158 |
77K |
1 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
158
|
77K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
VP research has departed SPL
|
|
Biostock
|
35 |
11K |
2 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
VP research has departed SPL
|
|
Biostock
|
35 |
11K |
2 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
VP research has departed SPL
|
|
Biostock
|
35 |
11K |
6 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
35
|
11K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Will TGA under Albo approve Viraleze?
|
|
Biostock
|
5 |
2.5K |
7 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
5
|
2.5K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
new interview
|
|
Biostock
|
30 |
8.2K |
6 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
30
|
8.2K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
new interview
|
|
Biostock
|
30 |
8.2K |
3 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
30
|
8.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze Update
|
|
Biostock
|
81 |
25K |
8 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
81
|
25K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 in VIRALEZE virucidal against influenza A and B
|
|
Biostock
|
40 |
10K |
5 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
40
|
10K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 in VIRALEZE virucidal against influenza A and B
|
|
Biostock
|
40 |
10K |
4 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
40
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze Update
|
|
Biostock
|
81 |
25K |
5 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
81
|
25K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Alan Kohler and David Langsam do your research
|
|
Biostock
|
3 |
1.9K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Another Interview-Executive Series 10 Jul 18: Starpharma (SPL) CEO, Dr Jackie Fairley
|
|
Biostock
|
24 |
10K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
24
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Alan Kohler and David Langsam do your research
|
|
Biostock
|
3 |
1.9K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Bye Bye Mundipharma
|
|
Biostock
|
23 |
6.3K |
3 |
15/05/22 |
15/05/22 |
ASX - By Stock
|
23
|
6.3K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
BOD
|
|
Biostock
|
34 |
9.7K |
4 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
34
|
9.7K
|
4
|
|
ASX - By Stock
|
SPL |
BOD
|
|
Biostock
|
34 |
9.7K |
16 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
34
|
9.7K
|
16
|
|
ASX - By Stock
|
SPL |
Re:
Quarterly Revenue Chart
|
|
Biostock
|
2 |
994 |
1 |
01/05/22 |
01/05/22 |
ASX - By Stock
|
2
|
994
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Wishful thinking this coming week
|
|
Biostock
|
62 |
17K |
4 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
62
|
17K
|
4
|
|